Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all.

[1]  R. Smith,et al.  Breast cancer screening among women younger than age 50: A current assessment of the issues , 2000, CA: a cancer journal for clinicians.

[2]  Karla Kerlikowske,et al.  Pathologic findings from the Breast Cancer Surveillance Consortium , 2006, Cancer.

[3]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[4]  Odd O Aalen,et al.  Breast cancer tumor growth estimated through mammography screening data , 2008, Breast Cancer Research.

[5]  Hesahm Najjar,et al.  Age at diagnosis of breast cancer in Arab nations. , 2010, International journal of surgery.

[6]  C. Baines.  Mammography screening: are women really giving informed consent? , 2003, Journal of the National Cancer Institute.

[7]  Edward Azavedo,et al.  Guidelines for International Breast Health and Cancer Control – Implementation Supplement to Cancer Guideline Implementation for Breast Healthcare in Low-Income and Middle-Income Countries Overview of the Breast Health Global Initiative Global Summit 2007 , 2008 .

[8]  L. Ries,et al.  Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEER. , 2006 .

[9]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[10]  J. Gray,et al.  Evidence-Based Healthcare: How to Make Health Policy and Management Decisions , 2001 .

[11]  P. Porter,et al.  "Westernizing" women's risks? Breast cancer in lower-income countries. , 2008, The New England journal of medicine.

[12]  B. Anderson.  Understanding social obstacles to early breast cancer detection is critical to improving breast cancer outcome in low‐ and middle‐resource countries , 2010, Cancer.

[13]  Gary L. Kreps,et al.  Guidelines for International Breast Health and Cancer Control – Implementation Supplement to Cancer Guideline Implementation for Breast Healthcare in Low-and Middle-Income Countries Early Detection Resource Allocation , 2008 .

[14]  Gerd Gigerenzer,et al.  Public Knowledge of Benefits of Breast and Prostate Cancer Screening in Europe , 2009, Journal of the National Cancer Institute.

[15]  Peter C Gøtzsche,et al.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends , 2009, BMJ : British Medical Journal.

[16]  A. Rothberg.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2008 .

[17]  A. Mckenzie.  Cancer of Female Breast , 1873, Atlanta medical and surgical journal.

[18]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[19]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[20]  Marvin Zelen,et al.  Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms , 2009 .

[21]  Harry J de Koning,et al.  Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. , 2008, Journal of the National Cancer Institute.

[22]  Maureen A Smith,et al.  Retrospective cost-effectiveness analysis of screening mammography. , 2006, Journal of the National Cancer Institute.

[23]  Marvin Zelen,et al.  Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.

[24]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[25]  Martin L. Brown,et al.  Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature , 2004, Breast Cancer Research and Treatment.

[26]  H. Freeman.  Patient navigation: a community centered approach to reducing cancer mortality. , 2006, Journal of cancer education : the official journal of the American Association for Cancer Education.

[27]  R. Nicholson,et al.  Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity , 2008, Breast Cancer Research.

[28]  Lisa M. Schwartz,et al.  Numbers needed to decide. , 2009, Journal of the National Cancer Institute.

[29]  Emily White,et al.  Factors contributing to mammography failure in women aged 40-49 years. , 2004, Journal of the National Cancer Institute.

[30]  L. Kiemeney,et al.  The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. , 2011, European journal of public health.

[31]  P. Boyle,et al.  The benefi ts and harms of breast cancer screening , 2013 .

[32]  E. Paci,et al.  The other side of technology: risk of overdiagnosis of breast cancer with mammography screening. , 2009, Future oncology.

[33]  C. J. Rosenquist,et al.  Screening mammography beginning at age 40 years , 1998, Cancer.

[34]  Paola Pisani,et al.  Outcome of screening by clinical examination of the breast in a trial in the Philippines , 2006, International journal of cancer.

[35]  Bruce L Daniel,et al.  Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. , 2006, JAMA.

[36]  E. Steliarova-Foucher,et al.  Cancer registration in developing countries: luxury or necessity? , 2008, The Lancet. Oncology.

[37]  H. Welch.  Screening mammography--a long run for a short slide? , 2010, The New England journal of medicine.

[38]  J. Elmore,et al.  Breast Cancer Screening for Women in Their 40s: Moving from Controversy about Data to Helping Individual Women , 2007, Annals of Internal Medicine.

[39]  P. Hall,et al.  Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: A comparative population‐based study in Singapore and Sweden , 2005, International journal of cancer.

[40]  Naglaa A. Abdelrazek,et al.  Women Health Outreach Program; a New Experience for all Egyptian Women. , 2008, Journal of the Egyptian National Cancer Institute.

[41]  M. Corbex,et al.  Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  N. E. El Saghir.  Responding to the challenges of breast cancer in egypt and other arab countries. , 2008, Journal of the Egyptian National Cancer Institute.

[43]  M. Manos,et al.  Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. , 2005, Journal of the National Cancer Institute. Monographs.

[44]  Joseph Lipscomb,et al.  Health Service Interventions for Cancer Control in Developing Countries , 2006 .

[45]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[46]  P. Gøtzsche,et al.  The benefits and harms of screening for cancer with a focus on breast screening. , 2010, Polskie Archiwum Medycyny Wewnetrznej.

[47]  Rob Baltussen,et al.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .

[48]  S. Plevritis,et al.  Cost-effectiveness of Screening BRCA 1 / 2 Mutation Carriers With Breast Magnetic Resonance Imaging , 2006 .

[49]  N. Saghir.  Responding to the challenges of breast cancer in egypt and other arab countries. , 2008 .

[50]  P. Porter,et al.  Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.

[51]  Helen Igene.  Global Health Inequalities and Breast Cancer: An Impending Public Health Problem for Developing Countries , 2008, The breast journal.

[52]  J. Marks,et al.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England , 2010, Journal of Medical Screening.